Related Experiment Video
Updated: Dec 2, 2025
RNAi Interference by dsRNA Injection into Drosophila Embryos
Published on: April 11, 2011
Modeling Mucopolysaccharidosis Type II in the Fruit Fly by Using the RNA Interference Approach
Laura Rigon1,2, Nicole Kucharowski1,3, Franka Eckardt1
1Molecular Developmental Biology Unit, Life & Medical Sciences Institute (LIMES), University of Bonn, Carl-Troll-Straße 31, 53115 Bonn, Germany.
Abstract:
Mucopolysaccharidosis type II (MPS II) is a lysosomal storage disorder that occurs due to the deficit of the lysosomal enzyme iduronate 2-sulfatase (IDS) that leads to the storage of the glycosaminoglycan heparan- and dermatan-sulfate in all organs and tissues. It is characterized by important clinical features and the severe form presents with a heavy neurological involvement. However, almost nothing is known about the neuropathogenesis of MPS II. To address this issue, we developed a ubiquitous, neuronal, and glial-specific knockdown model in Drosophila melanogaster by using the RNA interference (RNAi) approach. Knockdown of the Ids/CG12014 gene resulted in a significant reduction of the Ids gene expression and enzymatic activity. However, glycosaminoglycan storage, survival, molecular markers (Atg8a, Lamp1, Rab11), and locomotion behavior were not affected. Even strongly reduced, IDS-activity was enough to prevent a pathological phenotype in a MPS II RNAi fruit fly. Thus, a Drosophila MPS II model requires complete abolishment of the enzymatic activity.
Insights
Mucopolysaccharidosis type II (MPS II) research shows that even reduced enzyme activity can prevent disease symptoms. A complete loss of iduronate 2-sulfatase (IDS) activity is necessary to model MPS II neuropathogenesis in fruit flies.
Area of Science:
- Biochemistry
- Genetics
- Neuroscience
Background:
- Mucopolysaccharidosis type II (MPS II) is a lysosomal storage disorder caused by iduronate 2-sulfatase (IDS) deficiency.
- This deficiency leads to glycosaminoglycan accumulation in tissues, with severe neurological involvement in some cases.
- The neuropathogenesis of MPS II remains poorly understood.
Purpose of the Study:
- To investigate the neuropathogenesis of MPS II.
- To develop a reliable model for studying MPS II in *Drosophila melanogaster*.
Main Methods:
- Developed a *Drosophila* model using RNA interference (RNAi) for gene knockdown.
- Created ubiquitous, neuronal, and glial-specific knockdown of the *Ids/CG12014* gene.
- Assessed gene expression, enzyme activity, glycosaminoglycan storage, survival, molecular markers, and locomotion.
Main Results:
- Significant reduction in *Ids* gene expression and IDS enzymatic activity was achieved.
- No significant pathological phenotype, including glycosaminoglycan storage, was observed despite reduced IDS activity.
- Survival, molecular markers (Atg8a, Lamp1, Rab11), and locomotion remained unaffected.
Conclusions:
- A partial reduction in IDS activity is insufficient to cause a pathological phenotype in the fruit fly model.
- Complete abolishment of IDS enzymatic activity is required to establish a functional *Drosophila* model for MPS II neuropathogenesis.
- This suggests a threshold effect for IDS activity in preventing disease manifestation.
